Health Care & Life Sciences » Biotechnology | Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Arena Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
SPDR S&P Biotech ETF
1,518,045
3.08%
3,906
1.01%
09/06/2018
Fidelity Select Biotechnology Portfolio
1,280,644
2.6%
-59,629
0.54%
07/31/2018
Vanguard Small Cap Index Fund
1,237,766
2.5%
16,395
0.05%
07/31/2018
Vanguard Total Stock Market Index Fund
1,236,527
2.5%
1,150
0.01%
07/31/2018
Fidelity Contrafund
1,206,205
2.44%
-8,620
0.04%
07/31/2018
iShares Russell 2000 ETF
1,044,189
2.12%
-558
0.08%
09/06/2018
Vanguard Small Cap Growth Index Fund
707,014
1.43%
10,118
0.11%
07/31/2018
Vanguard Extended Market Index Fund
652,012
1.32%
6,100
0.04%
07/31/2018
Vanguard Explorer Fund
612,947
1.24%
0
0.14%
06/30/2018
iShares Nasdaq Biotechnology ETF
570,556
1.15%
-7,455
0.23%
09/06/2018

About Arena Pharmaceuticals

View Profile
Address
6154 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.arenapharm.com
Updated 07/08/2019
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.